Veeva Systems Partners with UCB to Enhance Pharmacovigilance Operations with Veeva Safety Suite

Veeva Systems (VEEV) forges a key partnership with UCB to enhance pharmacovigilance operations through the adoption of the Veeva Safety Suite. This strategic collaboration, initiated on June 9, 2026, seeks to standardize safety processes, thereby improving operational efficiency and data management in global safety operations. UCB aims to transition to this integrated platform to streamline workflows and establish a unified source of truth for safety data, which is crucial in today's regulatory landscape.

Innovative Solutions for Safety Management

The Veeva Safety Suite promises to equip UCB with comprehensive safety management tools that facilitate the processing of adverse events, safety-related content management, and advanced data analysis. Features like Veeva SafetyDocs and Veeva Safety Workbench will bolster UCB's capabilities in handling safety-related information, while Veeva Safety Signal will automate the critical signal detection process. According to Jonas Maselis, head of digital technology at UCB, this transition is pivotal to the company’s ongoing safety transformation efforts, enhancing oversight, and expediting submissions to health authorities.

Strengthening Global Compliance in Healthcare

John Lawrie, vice president of Veeva Safety, underscores the significance of this collaboration in delivering safe and effective medicines to patients around the world. By enhancing global compliance and boosting automation capabilities, this partnership represents a significant step towards more efficient pharmacovigilance practices. With over 1,500 clients, Veeva Systems continues to solidify its leadership position in the life sciences sector, catering to the needs of major pharmaceutical firms and innovative biotech companies alike.

Commitment to Transforming Patient Safety

In addition to the UCB partnership, Veeva Systems maintains a broader commitment to automating and standardizing healthcare data processes. This not only helps in regulatory compliance but also improves patient outcomes through better data management and reporting of adverse events. As the life sciences industry continues to evolve, Veeva Systems is well-positioned to innovate and adapt to meet new challenges and demands.

Looking Ahead

Overall, the strategic partnership with UCB illustrates Veeva's dedication to driving advancements in safety operations and emphasizes the importance of unified platforms in delivering healthcare solutions effectively. As Veeva continues to grow its product offerings and secure notable partnerships, its role in improving the pharmaceutical industry's efficiency and compliance remains crucial.